Original Research

Published on 05 Jun 2024

The effects of postoperative targeted immunotherapy on peripheral blood cytokines and immune cell profile in lung cancer patients

in Cancer Immunity and Immunotherapy

Chuang Zhang
Hongmei Mo
Min Li
Shuaiyan Wang
Xiaowen Dou
Xiuming Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1342624

1,100 views

Original Research

Published on 31 May 2024

Mathematical model of MMC chemotherapy for non-invasive bladder cancer treatment

in Cancer Immunity and Immunotherapy

Marom Yosef
Svetlana Bunimovich-Mendrazitsky

Frontiers in Oncology

doi 10.3389/fonc.2024.1352065

1,351 views
1 citation

Original Research

Published on 29 May 2024

IRX5’s influence on macrophage polarization and outcome in papillary thyroid cancer

in Cancer Immunity and Immunotherapy

Lu Qin
Cheng Chen
Zhengwei Gui
Yun Jiang

Frontiers in Oncology

doi 10.3389/fonc.2024.1399484

1,044 views
1 citation

Review

Published on 29 May 2024

State-of-the-art cytometry in the search of novel biomarkers in digestive cancers

in Cancer Immunity and Immunotherapy

Carolina G. de Castro
Alejandro G. del Hierro
Juan H-Vázquez
Sara Cuesta-Sancho
David Bernardo

Frontiers in Oncology

doi 10.3389/fonc.2024.1407580

1,269 views

Systematic Review

Published on 24 May 2024

Can adjuvant immune checkpoint inhibitors improve the long-term outcomes of hepatocellular carcinoma with high-risk recurrent factors after liver resection? A meta-analysis and systematic review

in Cancer Immunity and Immunotherapy

Lingbo Hu
Yenan Kong
Yingli Qiao
Aidong Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1374262

781 views

Case Report

Published on 24 May 2024

Case report: Regression after low-dose glucocorticoid therapy in a case of acute immune myocarditis induced by anti-PD-1 therapy for NSCLC

in Cancer Immunity and Immunotherapy

Liqianqi Chen
Suihao Zhang
Long Gong
Yucong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1404045

1,013 views
1 citation

Systematic Review

Published on 17 May 2024

Treatment-related adverse events of immune checkpoint inhibitors in clinical trials: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Xin Shen
Jun Yang
Geng Qian
Mingyu Sheng
Yu Wang
Guohui Li
Jiaqing Yan

Frontiers in Oncology

doi 10.3389/fonc.2024.1391724

1,023 views
3 citations

Systematic Review

Published on 16 May 2024

Global research trends in immunotherapy for non-small cell lung cancer patients with KRAS mutations: a bibliometric analysis

in Cancer Immunity and Immunotherapy

Hanyu Shen
Chunxiao Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1385761

1,623 views

Hypothesis and Theory

Published on 14 May 2024

Porphyromonas gingivalis, a bridge between oral health and immune evasion in gastric cancer

in Cancer Immunity and Immunotherapy

Matías Muñoz-Medel
Mauricio P. Pinto
Lauren Goralsky
Mónica Cáceres
Franz Villarroel-Espíndola
Patricio Manque
Andrés Pinto
Benjamin Garcia-Bloj
Tomas de Mayo
Juan A. Godoy

Frontiers in Oncology

doi 10.3389/fonc.2024.1403089

2,453 views
1 citation

Case Report

Published on 10 May 2024

Case report: Regression of in-transit metastases of cutaneous squamous cell carcinoma with combination pembrolizumab and topical diphencyprone

in Cancer Immunity and Immunotherapy

Dina Poplausky
Jade N. Young
Brandon R. Block
Yeriel Estrada
Giselle K. Singer
Vicky Wong
Patricia Cabral
Yamato Suemitsu
Randie H. Kim
Philip Friedlander

Frontiers in Oncology

doi 10.3389/fonc.2024.1294331

936 views

Mini Review

Published on 10 May 2024

The role of neck adipose tissue in lymph node metastasis of head and neck cancer

in Cancer Immunity and Immunotherapy

Yiqi Pan
Ying Xu
Cui Fan
Xiangwan Miao
Yilin Shen
Quan Wang
Jichang Wu
Haixia Hu
Hao Wang
Mingliang Xiang

Frontiers in Oncology

doi 10.3389/fonc.2024.1390824

1,034 views

Case Report

Published on 10 May 2024

Case report: Massive hepatocellular carcinoma with complete response to the non-surgical systematic treatment strategy

in Cancer Immunity and Immunotherapy

Yun Li
Yanzhen Lai
Xuqiang Luo
Jian Wu
Kunpeng Wu
Haiqing Ma

Frontiers in Oncology

doi 10.3389/fonc.2024.1291131

896 views

Case Report

Published on 10 May 2024

Case report: Long-term intracranial effect of zimberelimab monotherapy following surgical resection of high PD-L1-expressing brain metastases from NSCLC

in Cancer Immunity and Immunotherapy

Weijia Wu
Jinyou Guo
Lianxiang He
Qi Deng
Xianping Huang

Frontiers in Oncology

doi 10.3389/fonc.2024.1390343

861 views

Original Research

Published on 08 May 2024

Examination of the role of mutualism in immune evasion

in Cancer Immunity and Immunotherapy

Lucie Gourmet
Simon Walker-Samuel
Parag Mallick

Frontiers in Oncology

doi 10.3389/fonc.2024.1406744

754 views
1 citation

Systematic Review

Published on 02 May 2024

The risk of endocrine immune-related adverse events induced by PD-1 inhibitors in cancer patients: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Pengfei Zhao
Ting Zhao
Lihong Yu
Wenming Ma
Wenyu Liu
Chenning Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1381250

2,084 views

Original Research

Published on 02 May 2024

Predictive value of PD-L1 and TMB for short-term efficacy prognosis in non-small cell lung cancer and construction of prediction models

in Cancer Immunity and Immunotherapy

Shuling Shi
Yingyi Wang
Jingjing Wu
Boya Zha
Peihong Li
Yukun Liu
Yuchuan Yang
Jinglin Kong
Shibo Gao
Haiyang Cui

Frontiers in Oncology

doi 10.3389/fonc.2024.1342262

1,146 views

Navigation group

Articles

The effects of postoperative targeted immunotherapy on peripheral blood cytokines and immune cell profile in lung cancer patients

Mathematical model of MMC chemotherapy for non-invasive bladder cancer treatment

IRX5’s influence on macrophage polarization and outcome in papillary thyroid cancer

State-of-the-art cytometry in the search of novel biomarkers in digestive cancers

Can adjuvant immune checkpoint inhibitors improve the long-term outcomes of hepatocellular carcinoma with high-risk recurrent factors after liver resection? A meta-analysis and systematic review

Case report: Regression after low-dose glucocorticoid therapy in a case of acute immune myocarditis induced by anti-PD-1 therapy for NSCLC

Treatment-related adverse events of immune checkpoint inhibitors in clinical trials: a systematic review and meta-analysis

Global research trends in immunotherapy for non-small cell lung cancer patients with KRAS mutations: a bibliometric analysis

Porphyromonas gingivalis, a bridge between oral health and immune evasion in gastric cancer

Case report: Regression of in-transit metastases of cutaneous squamous cell carcinoma with combination pembrolizumab and topical diphencyprone

The role of neck adipose tissue in lymph node metastasis of head and neck cancer

Case report: Massive hepatocellular carcinoma with complete response to the non-surgical systematic treatment strategy

Case report: Long-term intracranial effect of zimberelimab monotherapy following surgical resection of high PD-L1-expressing brain metastases from NSCLC

Examination of the role of mutualism in immune evasion

The risk of endocrine immune-related adverse events induced by PD-1 inhibitors in cancer patients: a systematic review and meta-analysis

Predictive value of PD-L1 and TMB for short-term efficacy prognosis in non-small cell lung cancer and construction of prediction models